Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINHALATION, INTRAVENOUSGeneric

PENTETATE ZINC TRISODIUM

PENTETATE ZINC TRISODIUM

Standard Dose
EQ 1GM BASE/5ML (EQ 200MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview PENTETATE ZINC TRISODIUM is listed in Drugs@FDA under application 021751 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient PENTETATE ZINC TRISODIUM Form and strength SOLUTION;INHALATION, INTRAVENOUS - EQ 1GM BASE/5ML (EQ 200MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor HAMELN PHARMA PLUS Submission history Latest submission status date: 2013-03-21 00:00:00.

Structured Monograph

Clinical summary

Approval overview PENTETATE ZINC TRISODIUM is listed in Drugs@FDA under application 021751 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PENTETATE ZINC TRISODIUM Form and strength SOLUTION;INHALATION, INTRAVENOUS - EQ 1GM BASE/5ML (EQ 200MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor HAMELN PHARMA PLUS Submission history Latest submission status date: 2013-03-21 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.